My Son Seizes Without His Medication. Fortis Health Rejected It Three Times.

Chloe Bennett

I was picking up Dominic’s medication at the pharmacy counter when the insurance system REJECTED the claim for the third time in two weeks – and the pharmacist slid the paper back to me like it was my fault.

Dominic is seven, and he has a rare seizure disorder that took fourteen months to diagnose. The medication they rejected isn’t optional. Without it, he seizes. The last time we ran out, he coded in the school parking lot while I was still in scrubs from a twelve-hour shift.

I’ve been fighting this insurance company, Fortis Health, since he was six. I know how to fight – I’m an ER nurse, I document everything, I understand medical necessity better than most of their reviewers. But they keep denying, and Dominic keeps getting older, and I keep paying out of pocket.

That afternoon, the pharmacist – a young woman named Bria – leaned over the counter and said quietly, “This is the fourth patient this week with the same denial code. Same plan. Same drug class.”

I went still.

I started asking around. Not loudly. I talked to two other nurses at the hospital who had Fortis plans. Then I pulled my own explanation-of-benefits documents from the last eight months and laid them on the kitchen table.

The pattern was there.

Fortis was systematically denying a specific tier of neurological medications. Not randomly. SPECIFICALLY. Pediatric cases, chronic conditions, high-cost maintenance drugs.

I called a patient advocate I know named Terri Grasso. She told me she’d seen the same thing across three other hospitals in the county.

Then I filed a formal complaint with the state insurance commissioner. I documented every denial, every appeal, every out-of-pocket receipt. I attached Dominic’s seizure records. I attached the school incident report.

I sent a copy to a healthcare reporter named Paul Shin at the local paper.

I sent a copy to Fortis’s medical director directly, with a note that said: “I HAVE EVERYTHING.”

Two days later, Terri called me.

“Dana,” she said. “The commissioner’s office wants to talk. But there’s something else – Paul found something in Fortis’s internal review criteria, and you need to sit down before he reads it to you.”

What Paul Found

I was standing in the kitchen when Terri patched Paul in on a three-way call. It was a Tuesday, around 7pm. Dominic was in the next room watching something with dinosaurs. I remember that specifically because I could hear the roaring through the wall while Paul talked.

He’d gotten a document through a source he wouldn’t name. An internal Fortis clinical review guideline, dated eight months before Dominic’s first denial. It was titled something anodyne, the kind of title that’s designed to be boring on purpose. Paul read me the relevant section.

Fortis had built a cost-threshold trigger into their prior authorization review process for what they called “Tier 3 Neurological Maintenance Medications.” If a pediatric patient’s projected annual drug cost exceeded a certain dollar amount – Paul said the number, and I wrote it down, and then I looked at what Dominic’s medication cost per year – the claim was automatically flagged for what the document called “enhanced clinical scrutiny.”

Enhanced clinical scrutiny.

That’s the phrase they used. It means a reviewer who is not a neurologist, and in several documented cases not a physician at all, looked at the file and decided whether a seven-year-old with a documented seizure disorder actually needed his seizure medication.

The trigger amount was set just below Dominic’s annual prescription cost. Not by coincidence. The document showed it had been revised downward twice in eighteen months.

I sat down. I hadn’t planned to. My legs just did it.

“Dana?” Paul said.

“I’m here,” I said. “Keep going.”

The Part I Hadn’t Expected

Here’s what I thought was going to happen: I’d file the complaint, the commissioner’s office would investigate, Fortis would pay a fine that amounted to maybe three weeks of their quarterly profit, and Dominic would get his medication approved going forward. I’d seen that playbook before. I’d helped other families through versions of it. You fight, you win a small thing, the machine keeps running.

What I hadn’t expected was that Terri had also been talking to a family named the Kowalski-Garcias. Their daughter, Marta, was nine. Same diagnosis category as Dominic, different drug, same denial code. Marta had been denied eleven times. Eleven. Her parents had been paying $1,400 a month out of pocket for eight months and then they couldn’t anymore, and then Marta had a cluster seizure at home that put her in the ICU for four days.

Terri had their records. With their permission, she’d handed them to Paul too.

And then there was a man named Dennis Pruitt, who worked in Fortis’s appeals department and had quit six months earlier. He hadn’t gone public. He hadn’t talked to anyone. He’d just quit and gone to work for a small regional insurer outside the state.

Paul had found him.

Dennis hadn’t wanted to talk. Then Paul showed him the internal document. And Dennis, apparently, went very quiet for a long moment and then said he needed to call his wife.

He called Paul back two hours later.

What Dennis Said

I only know what Paul told me, and Paul was careful about what he’d confirmed versus what was still being checked. But here’s the shape of it.

Dennis had worked in Fortis’s appeals unit for four years. He said the cost-threshold trigger wasn’t a bug or an oversight. It had been presented internally as a “utilization management optimization.” He said that phrase like he’d had to say it enough times that it lived in a different part of his brain from the rest of his words.

There were quotas. Not written down anywhere Dennis had seen, but understood. Reviewers knew what approval rates were expected, and the expectation moved depending on the drug category and the cost tier. Pediatric neurological was one of the tightest.

He said he’d flagged it once to a supervisor. The supervisor told him the criteria had been reviewed by their medical advisory board and were clinically defensible.

Dennis said he’d asked to see the board’s review.

He was told it wasn’t available at his clearance level.

He quit four months after that conversation.

I’m an ER nurse. I’ve worked nights, I’ve coded kids, I’ve held parents in hallways while doctors talked. I don’t rattle easy. But I sat at my kitchen table with Paul’s voice in my ear and I thought about Dominic in that school parking lot, about the school secretary who’d administered his emergency medication while I drove ninety miles an hour through three red lights, and I felt something that wasn’t grief and wasn’t rage. It was colder than both of those.

I picked up my pen.

What the Commissioner’s Office Said

The meeting was a video call, eight people on their side including a deputy commissioner named Vickers and a woman from their fraud and market conduct division whose last name I didn’t catch but whose questions were the sharpest I’d heard outside a hospital ethics review.

They’d already started pulling claims data before we got on the call. My complaint had landed on top of two others that had come in that same week, from different parts of the state, about Fortis denial patterns. The timing wasn’t coordinated. It just happened that way. Three separate families, three separate complaints, same company, same pattern, same week.

The fraud division woman asked me to walk through my documentation. I did. She asked about Dominic’s seizure records, the school incident report, the out-of-pocket receipts. I’d organized everything by date and denial code. She said, “You did this yourself?” and I said yes and she made a note.

They told me they were opening a formal market conduct examination. That’s the regulatory term for a serious investigation. It means they can compel records, not just request them.

Vickers said they couldn’t discuss specifics of what they might find or what remedies might follow. He was careful about that. But he said something at the end of the call, almost like he was talking to himself: “The cost-threshold structure, if it’s what you’re describing, that’s not utilization management. That’s a coverage design decision dressed up as a clinical one.”

I wrote that down too.

Where Dominic Is Now

He’s asleep right now. He’s got a nightlight shaped like a turtle that projects stars on the ceiling, and he’s had it since he was four, and he’s going to be furious when he’s old enough to think it’s babyish. He’s missing a front tooth. He’s been missing it for six weeks because he’s convinced the tooth fairy is running a scam and he wants to investigate before he surrenders the tooth. He’s seven.

His neurologist, Dr. Vasquez, submitted a fourth prior authorization request the day after I sent my letter to Fortis’s medical director. The one with the note that said I HAVE EVERYTHING.

It was approved in forty-eight hours.

First approval in fourteen months.

I’m not naive enough to think that’s justice. That’s one kid, one approval, because his mother made enough noise in the right directions at the right time. There are families who don’t have a nurse in the house. Who don’t know what an explanation-of-benefits document is, or how to read a denial code, or who Terri Grasso is.

Marta Kowalski-Garcia got approved the same week. Her parents called Terri crying and Terri called me.

Dennis Pruitt gave a formal statement to the commissioner’s office. Paul’s story ran on a Thursday. By Friday it had been picked up by two regional outlets and one national healthcare trade publication.

Fortis issued a statement calling their review criteria “consistent with industry standards and evidence-based guidelines.” I read it twice. I know what that kind of language is for.

The examination is ongoing.

Vickers’s office told Terri they’re looking at three years of claims data. Pediatric neurological. High-cost maintenance drugs. The whole tier.

I go back to the ER on Monday. Twelve-hour shift, 7am to 7pm, same as always. I’ll probably see someone in the waiting room fighting with an insurance card. I’ll probably see a parent who looks the way I looked in that pharmacy, that specific expression people get when they’ve been told no so many times that they’ve stopped being surprised and started being something worse than surprised.

I don’t know what the examination finds. I don’t know what the fine looks like, if there is one, or what Fortis changes, if anything.

What I know is that Dominic’s medication is filled. It’s in the cabinet above the refrigerator in the orange bottle with his name on it. I checked it before I sat down to write this.

It’s there.

If you know a family fighting this same battle, send them this. Sometimes knowing someone else cracked the door open is enough to make them knock.

For another frustrating tale of insurance woes, read about The Insurance Company Denied My Daughter’s Seizure Medication for the Third Time, or if you’re in the mood for something completely different, check out My Wife Said She Was Going for a Walk Every Tuesday and Thursday and My Wife Told Her Other Family I Died Three Years Ago.